Video Experimental Relacionado
Updated: Sep 10, 2025
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.3K
Activación del factor de crecimiento transformador beta 1 a través de la integrina alfa V beta 6 y sus conocimientos
Vishal Kumar Deb1, Utkarsh Jain1
1School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand 248007, India.
International journal of biological macromolecules
|August 26, 2025
Resumen
La activación del factor de crecimiento transformador beta 1 (TGF-β1) por la integrina αVβ6 conduce a la metástasis del cáncer. Comprender esta interacción, incluidos los aminoácidos clave, es crucial para desarrollar terapias dirigidas contra el cáncer.
Área de la Ciencia:
- En el campo de la oncología
- Biología molecular
- La bioquímica
Sus antecedentes:
- La metástasis del cáncer es una etapa letal que implica la invasión de células cancerosas y el establecimiento en nuevos microambientes.
- El factor de crecimiento transformador-beta 1 (TGF-β1), un mediador clave, promueve la metástasis en varios cánceres como el colorrectal, el pulmón, el gástrico y el de próstata.
- El TGF-β1 latente requiere activación, siendo la integrina αVβ6 un activador crucial relacionado con el desarrollo tumoral.
Objetivo del estudio:
- Revisar los mecanismos de activación del TGF-β1, con un enfoque en la integrina αVβ6.
- Aclarar los aspectos estructurales de la activación del TGF-β1 por la integrina αVβ6 y otras proteínas.
- Identificar las funciones de los aminoácidos implicados en la interacción latente del TGF-β1 y la integrina αVβ6 para el desarrollo terapéutico.
Principales métodos:
- Revisión de la literatura que resume los conocimientos actuales sobre las vías de activación del TGF-β1.
- Análisis de las interacciones estructurales entre el TGF-β1 latente y sus activadores, particularmente la integrina αVβ6.
- Examen del papel de los aminoácidos específicos en la mediación de estas interacciones.
Principales resultados:
- Integrin αVβ6 es un activador crítico del TGF-β1 latente, que influye en la señalización descendente y la adhesión celular.
- Integrin αVβ6 también activa el MMP-9, contribuyendo a la transición epitelio-mesenquimal (EMT).
- Otras proteínas como la trombospondina-1 y las proteasas ADAMTS 1 también pueden activar el TGF-β1 latente.
Conclusiones:
- La integrina αVβ6 juega un papel fundamental en la activación del TGF-β1 y la progresión del cáncer.
- Comprender la base estructural y la participación de los aminoácidos en la activación latente del TGF-β1 por la integrina αVβ6 es vital.
- Este conocimiento puede guiar el desarrollo de nuevos tratamientos contra el cáncer dirigidos al eje TGF-β1 / integrina αVβ6.
Videos de Conceptos Relacionados
01:16TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
01:15Activation of Integrins
3.6K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.6K
01:10Integrins
4.1K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.1K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K